Progressive multifocal leukoencephalopathy with immune reconstitution inflammatory syndrome misdiagnosed as cerebral toxoplasmosis in an HIV-infected woman  by Durel, Cécile-Audrey et al.
International Journal of Infectious Diseases 36 (2015) 70–71Medical Imagery
Progressive multifocal leukoencephalopathy with immune
reconstitution inﬂammatory syndrome misdiagnosed as cerebral
toxoplasmosis in an HIV-infected woman§
Figure 1. Cerebral magnetic resonance imaging: (A) multifocal ring-enhancing lesions; (B) image enhancement fading within 3 months of oral steroid therapy.
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j idA 53-year-old woman presenting with oral candidiasis was
diagnosed with HIV-1 infection. The CD4 cell count nadir was
71 cells/mm3 (5%) and viral load was 445 000 copies/ml. Treatment
was initiated with emtricitabine/tenofovir and boosted darunavir.
One month later, she presented seizures with psychomotor
slowdown, left upper-limb paresis, cerebellar syndrome, left
homonymous hemianopsia, and cortical blindness. Her HIV viral§ Ce´cile-Audrey Durel, Thomas Perpoint, and Florent Valour contributed equally
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).load had decreased dramatically (968 copies/ml); the CD4 count
was 57 cells/mm3 (9%). Cerebral magnetic resonance imaging
identiﬁed multifocal ring-enhancing lesions (Figure 1A). Although
other diagnoses could have been considered, cerebral toxoplas-
mosis was suspected on the grounds of frequency, and sulfadia-
zine–pyrimethamine was initiated. Two weeks later, the seizures
recurred and progressive multifocal leukoencephalopathy (PML)
was ﬁnally diagnosed from the presence of JC virus DNA in
cerebrospinal ﬂuid, serum, and brain biopsy. Cerebral toxoplas-
mosis was ruled out by the small mass effect of cerebral lesions and
the absence of Toxoplasma DNA in the brain. Despite a moderateciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Medical Imagery / International Journal of Infectious Diseases 36 (2015) 70–71 71change in CD4 cell count, immune reconstitution inﬂammatory
syndrome (IRIS) was suggested by the atypical contrast
enhancement pattern.1 Brain histology conﬁrmed overwhelming
CD8 T-cell inﬁltration, congruent with criteria for PML–IRIS.2
Steroids and mirtazapine were initiated to slow down brain
deterioration. Fading of contrast enhancement within 3 months
conﬁrmed the diagnosis of PML–IRIS (Figure 1B). PML–IRIS
should be considered as a differential diagnosis to toxoplasmosis
in moderate oedematous lesions, especially after the initiation of
highly active antiretroviral therapy, and regardless of variation in
CD4 cell count.3
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